"Marshfield Medical Center - River Region Stevens Point Campus (medical offices), previously known as Stevens Point Center, offers primary and specialty care for all ages. With urgent care, lab and optical all in one location, Stevens Point provides care when, where and how you want it. Additionally, the campus offers CT scan, ultrasound, X-ray and mobile imaging services. It is adjacent to the hospital, which offers 24/7 care. Services at this location include: Cancer care Dermatology Eye care Family practice Oral surgery Pediatrics Podiatry Physical and occupational therapy Sports medicine Urgent care is available Monday-Friday, 7:30 a.m. to 7:30 p.m."

During the past decade, Marshfield Medical Center-River Region at Stevens Point conducted 100 clinical trials. In the 10-year time frame, 100 clinical trials started and 7 clinical trials were completed, i.e. on average, 7% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 7 clinical trials were completed. i.e. 13% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marshfield Medical Center-River Region at Stevens Point" #1 sponsor was "National Cancer Institute (NCI)" with 74 trials, followed by "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "NRG Oncology" with 7 trials sponsored and "SWOG Cancer Research Network" with 7 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marshfield Medical Center-River Region at Stevens Point" #1 collaborator was "National Cancer Institute (NCI)" with 27 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Marshfield Medical Center-River Region at Stevens Point" are "Clinical Stage IV Cutaneous Melanoma AJCC v8" (6 trials), "Clinical Stage III Cutaneous Melanoma AJCC v8" (5 trials), "Stage IIIB Lung Cancer AJCC v8" (5 trials), "Stage IV Lung Cancer AJCC v8" (5 trials) and "Lung Non-Squamous Non-Small Cell Carcinoma" (4 trials). Many other conditions were trialed in "Marshfield Medical Center-River Region at Stevens Point" in a lesser frequency.

Most popular intervention types in "Marshfield Medical Center-River Region at Stevens Point" are "Drug" (80 trials), "Other" (58 trials), "Procedure" (52 trials), "Biological" (51 trials) and "Radiation" (25 trials). Other intervention types were less common.

The name of intervention was led by "Computed Tomography" (35 trials), "Biospecimen Collection" (33 trials), "Quality-of-Life Assessment" (32 trials), "Magnetic Resonance Imaging" (23 trials) and "Nivolumab" (22 trials). Other intervention names were less common.

The vast majority of trials in "Marshfield Medical Center-River Region at Stevens Point" are 85 trials for "All" genders, 11 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Marshfield Medical Center-River Region at Stevens Point". undefined are not yet recruiting, 54 are recruiting, 41 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Marshfield Medical Center-River Region at Stevens Point, 5 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Marshfield Medical Center-River Region at Stevens Point, 3 "Phase 1" clinical trials were conducted, 54 "Phase 2" clinical trials and 56 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".